Journal of Cardiothoracic and Vascular Anesthesia
Volume 22, Issue 2 , Pages 217-224 , April 2008

Anesthetic Preconditioning Decreases Arrhythmias and Improves Regional Conduction in Isolated Hearts

  • Leo G. Kevin, MD, FCARCSI

      Affiliations

    • Department of Anesthesiology, The Heart Hospital, London, United Kingdom
    • University Department of Anaesthesia, National University of Ireland, Galway, Ireland
    • ,
  • Enis Novalija, MD, PhD

      Affiliations

    • Department of Anesthesiology, Medical College of Wisconsin, Milwaukee, WI.
    • Corresponding Author InformationAddress reprint requests to Enis Novalija, MD, PhD, Medical College of Wisconsin, Department of Anesthesiology, M4280, 8701 Watertown Plank Road, Milwaukee, WI 53226.

References 

  1. Zaugg M, Lucchinetti E, Uecker M, et al. Anaesthetics and cardiac preconditioning (Part I. Signalling and cytoprotective mechanisms). Br J Anaesth. 2003;91:551–565
  2. Tanaka K, Ludwig LM, Kersten JR, et al. Mechanisms of cardioprotection by volatile anesthetics. Anesthesiology. 2004;100:707–721
  3. De Hert SG, Turani F, Mathur S, et al. Cardioprotection with volatile anesthetics: Mechanisms and clinical implications. Anesth Analg. 2005;100:1584–1593
  4. Schuger CD, Jackson K, Steinman RT, et al. Atrial sensing to augment ventricular tachycardia detection by the automatic implantable cardioverter-defibrillator: A utility study. Pacing Clin Electrophysiol. 1988;11:1456–1464
  5. Walsh CA, Singer LP, Mercando AD, et al. Differentiation of arrhythmias in the dog by measurement of activation sequence using an atrial and two ventricular electrodes. Pacing Clin Electrophysiol. 1988;11:1732–1738
  6. Ropella KM, Baerman JM, Sahakian AV, et al. Differentiation of ventricular tachyarrhythmias. Circulation. 1990;82:2035–2043
  7. Ropella KM, Sahakian AV, Baerman JM, et al. The coherence spectrum (A quantitative discriminator of fibrillatory and nonfibrillatory cardiac rhythms). Circulation. 1989;80:112–119
  8. Guiding principles for research involving animals and human beings. Am J Physiol Regul Integr Comp Physiol. 2002;283:281–283
  9. U.S. National Institutes of Health. Guide for the Care and Use of Laboratory Animals (U.S. National Institutes of Health No. 85-2). Bethesda, MD: U.S. National Institutes of Health; 1996;
  10. Novalija E, Fujita S, Kampine JP, et al. Sevoflurane mimics ischemic preconditioning effects on coronary flow and nitric oxide release in isolated hearts. Anesthesiology. 1999;91:701–712
  11. Novalija E, Varadarajan SG, Camara AK, et al. Anesthetic preconditioning: Triggering role of reactive oxygen and nitrogen species in isolated hearts. Am J Physiol Heart Circ Physiol. 2002;283:H44–H52
  12. Ludwig LM, Patel HH, Gross GJ, et al. Morphine enhances pharmacological preconditioning by isoflurane: Role of mitochondrial K(ATP) channels and opioid receptors. Anesthesiology. 2003;98:705–711
  13. Kehl F, Krolikowski JG, Mraovic B, et al. Is isoflurane-induced preconditioning dose related?. Anesthesiology. 2002;96:675–680
  14. Warltier DC, Zyvoloski MG, Gross GJ, et al. Determination of experimental myocardial infarct size. J Pharmacol Methods. 1981;6:199–210
  15. Altman FP. Tetrazolium salts and formazans. Prog Histochem Cytochem. 1976;9:1–56
  16. Walker MJ, Curtis MJ, Hearse DJ, et al. The Lambeth Conventions: Guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovasc Res. 1988;22:447–455
  17. Wallenstein S, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research. Circ Res. 1980;47:1–9
  18. Kevin LG, Katz P, Camara AK, et al. Anesthetic preconditioning: Effects on latency to ischemic injury in isolated hearts. Anesthesiology. 2003;99:385–391
  19. Bernier M, Hearse DJ, Manning AS. Reperfusion-induced arrhythmias and oxygen-derived free radicals (Studies with “anti-free radical” interventions and a free radical- generating system in the isolated perfused rat heart). Circ Res. 1986;58:331–340
  20. Avkiran M, Ibuki C. Reperfusion-induced arrhythmias (A role for washout of extracellular protons?). Circ Res. 1992;71:1429–1440
  21. Cinca J, Warren M, Carreno A, et al. Changes in myocardial electrical impedance induced by coronary artery occlusion in pigs with and without preconditioning: Correlation with local ST-segment potential and ventricular arrhythmias. Circulation. 1997;96:3079–3086
  22. Botsford MW, Lukas A. Ischemic preconditioning and arrhythmogenesis in the rabbit heart: effects on epicardium versus endocardium. J Mol Cell Cardiol. 1998;30:1723–1733
  23. Zhu J, Ferrier GR. Ischemic preconditioning: antiarrhythmic effects and electrophysiological mechanisms in isolated ventricle. Am J Physiol. 1998;274:H66–H75
  24. Kersten JR, Schmeling TJ, Pagel PS, et al. Isoflurane mimics ischemic preconditioning via activation of KATP channels: Reduction of myocardial infarct size with an acute memory phase. Anesthesiology. 1997;87:361–370
  25. Marinovic J, Bosnjak ZJ, Stadnicka A. Preconditioning by isoflurane induces lasting sensitization of the cardiac sarcolemmal adenosine triphosphate-sensitive potassium channel by a protein kinase C-delta-mediated mechanism. Anesthesiology. 2005;103:540–547
  26. Bril A. Cellular mechanisms of cardiac arrhythmias in the ischemic and reperfused heart. EXS. 1996;76:135–153
  27. Hicks JJ, Montes-Cortes DH, Cruz-Dominguez MP, et al. Antioxidants decrease reperfusion-induced arrhythmias in myocardial infarction with ST-elevation. Front Biosci. 2007;12:2029–2037
  28. Kevin LG, Novalija E, Riess ML, et al. Sevoflurane exposure generates superoxide but leads to decreased superoxide during ischemia and reperfusion in isolated hearts. Anesth Analg. 2003;96:949–955
  29. Garcia-Rivas Gde J, Carvajal K, Correa F, et al. Ru360, a specific mitochondrial calcium uptake inhibitor, improves cardiac post-ischaemic functional recovery in rats in vivo. Br J Pharmacol. 2006;149:829–837
  30. Riess ML, Camara AK, Novalija E, et al. Anesthetic preconditioning attenuates mitochondrial Ca2+ overload during ischemia in guinea pig intact hearts; reversal by 5-hydroxydecanoic acid. Anesth Analg. 2002;95:1540–1546
  31. Yue Y, Qu Y, Boutjdir M. Protective role of protein kinase C epsilon activation in ischemia-reperfusion arrhythmia. Biochem Biophys Res Commun. 2006;349:432–438
  32. Novalija E, Kevin LG, Camara AK, et al. Reactive oxygen species precede the epsilon isoform of protein kinase C in the anesthetic preconditioning signaling cascade. Anesthesiology. 2003;99:421–428
  33. Shiki K, Hearse DJ. Preconditioning of ischemic myocardium: Reperfusion-induced arrhythmias. Am J Physiol. 1987;253:H1470–H1476
  34. Vegh A, Szekeres L, Parratt J. Preconditioning of the ischaemic myocardium; Involvement of the L-arginine nitric oxide pathway. Br J Pharmacol. 1992;107:648–652
  35. Driamov S, Bellahcene M, Ziegler A, et al. Antiarrhythmic effect of ischemic preconditioning during low-flow ischemia (The role of bradykinin and sarcolemmal versus mitochondrial ATP-sensitive K(+) channels). Basic Res Cardiol. 2004;99:299–308
  36. Curtis MJ, Macleod BA, Walker MJ. Models for the study of arrhythmias in myocardial ischaemia and infarction: The use of the rat. J Mol Cell Cardiol. 1987;19:399–419
  37. De Hert SG, Van der Linden PJ, Cromheecke S, et al. Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Anesthesiology. 2004;101:299–310

 Supported by grant nos. 0360042Z from the American Heart Association-Greater Midwest Affiliate; PO1GM066730 from the National Institutes of Health, Bethesda, MD; and MCW Institutional Grant (to E.N.).

PII: S1053-0770(07)00162-0

doi: 10.1053/j.jvca.2007.05.007

Journal of Cardiothoracic and Vascular Anesthesia
Volume 22, Issue 2 , Pages 217-224 , April 2008

Article Tools

* Image Usage & Resolution